A new medical-grade Amodel® PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Syensqo today launched a new medical-grade Amodel® polyphthalamide (PPA). The glass-filled polymer is engineered for advanced single-use medical devices, delivering exceptional heat resistance, robust electrical properties, and key biocompatibility requirements for limited contact duration medical applications.
Amodel® PPA features a high melting point above 300 °C and maintains mechanical strength at temperatures up to 280 °C. These properties make it ideal for demanding manufacturing processes such as surface-mount technology (SMT) assembly, infrared (IR) reflow, and metal overmolding. The material is particularly well-suited for electrosurgical instruments and electronic device assemblies, where complex, injection-molded geometries offer advantages over alternative materials.
For decades, brands like Radel® and Udel® have helped advance medical technologies. With medical-grade Amodel® PPA, we’re extending that legacy, giving customers a new option for devices that must withstand modern assembly processes.
Amodel® PPA medical-grade is available for sampling, with commercial availability expected in 2026. High-resolution images are available upon request.
Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.
Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.
Learn more at www.syensqo.com.